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Abstract
Resveratrol (3,5,4V-trans-trihydroxystilbene) is a natural phytoalexin present in grapes and red wine, which possesses a variety of
biological activities including antioxidative activity. To find more efficient antioxidants by structural modification, resveratrol analogues, that
is, 3,4-dihydroxy-trans-stilbene (3,4-DHS), 4,4V-dihydroxy-trans-stilbene (4,4V-DHS), 4-hydroxy-trans-stilbene (4-HS) and 3,5-dihydroxy-
trans-stilbene (3,5-DHS), were synthesized and their antioxidant activity studied for the free radical-induced peroxidation of rat liver
microsomes in vitro. The peroxidation was initiated by either a water-soluble azo compound 2,2V-azobis(2-amidinopropane hydrochloride)
(AAPH) or Fe2 +/ascorbate, and monitored by oxygen uptake and formation of thiobarbituric acid reactive substances (TBARS). It was found
that all of these trans-stilbene derivatives are effective antioxidants against both AAPH- and iron-induced peroxidation of rat liver
microsomes with an activity sequence of 3,4-DHS>4,4V-DHS>resveratrol>4-HS>3,5-DHS. The remarkably higher antioxidant activity of
3,4-DHS is discussed.
D 2002 Published by Elsevier Science B.V.
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1. Introduction
Resveratrol (3,5,4V-trihydroxy-trans-stilbene) is a natu-
rally occurring phytoalexin present in grapes and many other
plants. It was found recently that this compound possesses a
variety of biological activities [1–9]. For instance, its
presence at high level in red wine (0.1–15 mg/l) [1] has
been suggested to be linked to the low incidence of heart
diseases in some regions of France, the so-called ‘‘French
paradox’’, that is, despite high fat intake, mortality from
coronary heart disease is lower due to the regular drinking
of wine [2]. In addition, resveratrol has been shown to
possess cancer chemopreventive activity [3,4]. Therefore,
the past several years have witnessed intense research
devoted to the biological activity, especially the antioxida-
tive activity, of this compound [4b,4c,5–9], since free
radical-induced peroxidation of membrane lipids and oxi-
dative damage of DNA have been considered to be asso-
ciated with a wide variety of chronic health problems, such
as cancer, atherosclerosis and aging [10–12], and gene
transcription can be regulated by oxidants, antioxidants
and other determinants of the intracellular redox state
[13]. Resveratrol has been reported to be a good antioxidant
against the peroxidation of low-density lipoprotein (LDL)
[6] and liposomes [7], a potent inhibitor of lipoxygenase [8],
and able to protect rat heart from ischaemia reperfusion
injury [9]. As a part of our ongoing research project on
antioxidative effects of natural antioxidants and their deriv-
atives [14], we found recently that some resveratrol deriv-
atives bearing an ortho-diphenoxyl functionality possess
much higher antioxidative activity against free radical-
induced peroxidation in membrane mimetic systems [15].
Therefore, it is desirable to see if the same structure/activity
relationship is also valid in biological systems. We report
herein an in vitro study on the antioxidative effect of
resveratrol and related trans-stilbene analogues, that is,
3,4-dihydroxy-trans-stilbene (3,4-DHS), 4,4V-dihydroxy-
trans-stilbene (4,4V-DHS), 4-hydroxy-trans-stilbene (4-HS)
and 3,5-dihydroxy-trans-stilbene (3,5-DHS), on free radi-
cal-induced peroxidation of rat liver microsomes. Micro-
somes, especially smooth surfaced endoplasmic reticulum,
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are particularly susceptible to oxidative stress because of the
high content of polyunsaturated fatty acids, hence have been
widely used as a model for oxidative stress and antioxidant
studies [16]. The peroxidation was initiated by a water-
soluble azo initiator 2,2V-azobis(2-amidinopropane hydro-
chloride) (AAPH) and Fe2 +/ascorbate and measured by
oxygen uptake and formation of thiobarbituric acid reactive
substances (TBARS). It was found that resveratrol and its
analogues, especially 3,4-DHS, are good antioxidants for
both peroxy radical- and hydroxy radical-initiated perox-
idation of rat liver microsomes.
2. Materials and methods
2.1. Materials
Resveratrol and its analogues 4-HS, 3,5-DHS, 4,4V-DHS
and 3,4-DHS were synthesized with reference to the avail-
able method [17]. This procedure gave exclusively the
trans-isomer and their structures were fully identified with
1H NMR and EI-MS and the data are consistent with those
reported in the literature [17]. The purity of the compounds
was checked by HPLC. AAPH and butylated hydroxyto-
luene (BHT) were purchased from Aldrich. Thiobarbituric
acid (TBA) was from Sigma. All other chemicals were of
the highest quality available.
2.2. Preparation of rat liver microsomes
Female Wister rats weighing 250F 20 g were starved
overnight before cervical dislocation. Liver microsomes were
prepared by tissue homogenization with ice-cold 0.25 M
sucrose–0.01 M Tris buffer, pH 7.4, with 1 mM EDTA (STE
buffer), in a motor-driven glass homogenizer [18]. Micro-
somal fractions were isolated by removal of the nuclear
faction at 8000 g for 10 min and removal of mitochondrial
fraction at 18,000 g for 10 min. The microsomal fraction
was sedimented in a Hitachi 55P-72 ultracentrifuge at
105,000 g for 60 min, washed two times with 0.15 M
KCl at 105,000 g for 30 min. The membranes, suspended
in 0.1M potassium phosphate buffer, pH 7.5, were stored in a
deep freezer maintained at  20 jC. Microsomal protein was
determined by the method of Lowry et al. [19].
2.3. Oxygen uptake measurements
The rate of oxygen uptake was measured in a closed glass
vessel of ca. 2 ml in volume, thermostated at 37F 0.1 jC
and provided with a magnetic stirrer, using a 5946-50
oxygen meter (Cole-Parmer Instruments, USA) which was
able to record oxygen concentration as low as 10 8 M. Rat
Fig. 1. Representative oxygen uptake curves recorded during the AAPH-
induced and ROH-inhibited peroxidation of rat liver microsomes at 37 jC.
The rat liver microsomes were suspended in 0.1 M potassium phosphate
buffer (pH 7.5) at a protein concentration of 2.0 mg/ml. [AAPH]0 = 8 mM;
[ROHs]0 = 5 AM. (a) Native microsomes; (b) 3,5-DHS; (c) 4-HS; (d)
resveratrol; (e) 4,4V-DHS; (f) 3,4-DHS. (A) The ROHs were added after the
inhibition period and the arrow shows the position of adding the ROHs. (B)
The ROHs were added before AAPH initiation.
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liver microsomes were suspended in 0.1 M potassium
phosphate buffer to the final concentration of 2.0 mg
protein/ml. Resveratrol and its analogues (ROHs) were
dissolved in DMSO to the concentration of 4.0 mM as stock
solutions. The final concentration of DMSO in the suspen-
sion was less than 0.1% (v/v) that did not show appreciable
interference to the reaction as evidenced by control experi-
ments. AAPH was directly dissolved in the phosphate buffer
(pH 7.5) and then injected into the suspension to initiate the
peroxidation. Every experiment was repeated three times
and values represent meanF S.E. of the experiments.
2.4. Measurements of TBARS
The formation of TBARS was used to monitor lipid
peroxidation [20]. Rat liver microsomes were incubated at
37 jC in 0.1 M potassium phosphate buffer, pH 7.5, and
made up to a final protein concentration of 0.3–0.5 mg/ml.
The peroxidation was initiated by either AAPH or Fe2 +/
ascorbate and inhibited by ROHs which were added as an
ethanol solution to the microsomal suspension and homo-
genized using a glass homogenizer. The final concentration
of ethanol in the suspension was less than 0.5% v/v that
did not show appreciable interference to the reaction as
evidenced by control experiments. The reaction mixture
was gently shaken at 37 jC and aliquots of the reaction
mixture were taken out at specific intervals to which a
TCA–TBA–HCl stock solution (15% w/v trichloroacetic
acid; 0.375% w/v TBA; 0.25 N HCl) was added, together
with 0.02% w/v BHT. This amount of BHT completely
prevents the formation of any nonspecific TBARS, as well
as preventing decomposition of AAPH during the subse-
quent boiling [21]. The solution was heated in a boiling
water bath for 15 min. After cooling, the precipitate was
removed by centrifugation. TBARS in the supernatant was
determined at 532 nm using the extinction coefficient of
1.56 105 M 1 cm 1 [20].
2.5. Determination of a-tocopherol (TOH)
TOH in rat liver microsomes was firstly extracted by
hexane–ethanol partitioning (hexane:EtOH:microsomes =
12:3:1 v/v/v) as described previously [14c], which yielded
>97% of TOH [22]. Then the TOH was separated by a
Gilson model 702 liquid chromatograph with a Sychropack
KPP-100 reversed-phase column (4 250 mm) and eluted
with methanol– iso-propanol–formic acid (80:20:1 v/v/v)
containing 50 mM of sodium perchlorate as a supporting
electrolyte at a flow rate of 1 ml/min and determined elec-
trochemically by using a Gilson Model 142 electrochemical
detector by setting the oxidation potential at + 700 mV.
3. Results
3.1. Inhibition of AAPH-induced microsomal peroxidation
by ROHs as studied by oxygen uptake
Fig. 1 shows representative oxygen uptake curves
recorded during the water-soluble azo initiator AAPH-
induced rat liver microsomal peroxidation. In the absence
of exogenous antioxidants, the oxygen uptake was still
inhibited for about 16 min (Fig. 1A, line a), demonstrating
the presence of endogenous antioxidants in the microsomes,
for example, a tocopherol, and ubiquinol-10 [12a], which
can trap the initiating and/or propagating peroxyl radicals to
inhibit the microsomal peroxidation. The oxygen uptake rate
during the inhibition period is designated as Rinh. After the
inhibition period, the oxygen uptake turned to faster, indi-
cating depletion of the endogenous antioxidants. The turn-
Table 1
Kinetic parameters for the AAPH-induced peroxidation of rat liver microsomes and its inhibition by ROHsa
Antioxidant Rinh (nM/s) Rp (nM/s) tinh (min) S.E. (%) Rinh/Rp (%) tinh (AH)/tinh
(ROH+AH)
AHb 39.9F 0.6 82.1F 4.2 16.3F 0.3 48.6
3,4-DHSc 29.8F 0.3 36.3
4,4V-DHSc 43.3F 3.2 52.7
Resveratrolc 55.9F 4.1 68.1
3,5-DHSc 72.4F 2.5 88.2
4-HSc 65.6F 1.2 79.9
3,4-DHSd 34.8F 1.5 52.4F 0.6 53.7F 0.6 229.4 0.30
4,4V-DHSd 40.8F 1.7 71.6F 4.0 38.5F 2.3 136.2 0.42
Resveratrold 44.8F 1.4 73.4F 3.9 27.8F 1.0 70.6 0.58
3,5-DHSd 44.6F 0.5 71.8F 4.5 17.5F 1.3 7.4 0.93
4-HSd 46.1F 3.0 70.0F 4.5 18.0F 1.7 10.4 0.90
a Peroxidation was monitored by oxygen uptake assay. The microsomes were suspended in 0.1 M phosphate buffer, pH 7.5, with protein concentration of
2.0 mg/ml; [AAPH]0 = 8 mM. [ROHs]0 = 5 AM. The data represent the means of three experiments.
b Endogenous antioxidants in rat liver microsomes.
c Added after depletion of the endogenous antioxidants.
d Added before the initiation.
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ing point from the inhibition period to the restoration of
oxygen uptake refers to inhibition time, tinh. The slope of the
oxygen uptake curves after the inhibition period represents
the intrinsic peroxidation rate, Rp, of the microsomes in the
absence of antioxidants.
After a short time of the inhibition period, 5 AM resver-
atrol and its analogues (ROHs), that is, 3,4-DHS, 4,4V-DHS,
4-HS and 3,5-DHS, were added. It was found that all of
these ROHs decreased the rate of oxygen uptake, but no
inhibition period was observed (Fig. 1A, lines b–f). The
kinetic behavior is similar to that of the AAPH-initiated
peroxidation of linoleic acid in homogenous solution re-
ported previously [23]. The decrease of the oxygen uptake
rate follows the sequence of 3,4-DHS>4,4V-DHS>resvera-
trol>4-HSf 3,5-DHS. The kinetic data are listed in Table 1.
It is worth to note that although ROHs did not produce
inhibition period when they were used alone (Fig. 1A, lines
b–f), they increased remarkably the inhibition period of the
native rat liver microsomes when the same amount of ROHs
was added to the microsomal suspension before the initia-
tion (Fig. 1B, lines b–f), revealing a synergistic antioxidant
Fig. 3. Inhibition of TBARS formation during the AAPH-induced
peroxidation of rat liver microsomes by resveratrol at 37 jC. The rat liver
microsomes were suspended in 0.1 M potassium phosphate buffer (pH 7.5)
at a protein concentration of 0.5 mg/ml. The peroxidation was initiated with
8 mM of AAPH and the initial concentrations of resveratrol were (a) 0,
(b) 5, (c) 10, (d) 15 and (e) 20 AM, respectively. Values represent meanF
S.E. of three experiments.
Fig. 4. Inhibition of TBARS formation during the AAPH-induced
peroxidation of rat liver microsomes by ROHs at 37 jC. The rat liver
microsomes were suspended in 0.1 M potassium phosphate buffer (pH 7.5)
at a protein concentration of 0.5 mg/ml. [AAPH]0 = 8 mM; [ROHs]0 = 15
AM. (a) Native microsomes; (b) 3,5-DHS; (c) 4-HS; (d) resveratrol; (e)
4,4V-DHS; (f) 3,4-DHS. Values represent meanF S.E. of three experiments.
Fig. 2. Formation of TBARS during the AAPH-induced peroxidation of
rat liver microsomes at 37 jC. The rat liver microsomes were suspended
in 0.1 M potassium phosphate buffer (pH 7.5) at a protein concentration
of 0.5 mg/ml. The initial concentrations of AAPH were (a) 0, (b) 2, (c) 8
and (d) 20 AM, respectively. Values represent meanF S.E. of three
experiments.
Fig. 5. Inhibition of TBARS formation during the Fe2 +/ascorbate-induced
peroxidation of rat liver microsomes by ROHs at 37 jC. The rat liver
microsomes were incubated in 0.1 M potassium phosphate buffer (pH 7.5)
at a protein concentration of 0.3 mg/ml for 30 min. [FeSO4] = 10 AM,
[ascorbate] = 100 AM. ROHs were added before the initiation with the
initial concentrations of 0.13, 0.25, 0.5, 1.0 and 2.0 AM, respectively, as
shown in the figure. Values represent meanF S.E. of three experiments.
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effect of ROHs with the endogenous antioxidants in the rat
liver microsomes, that is, the inhibition period of the micro-
somes was increased appreciably longer than the sum of the
intrinsic tinh of the native microsomes and the tinh induced
by ROHs when they were used alone (compare Fig. 1A and
B). The increase of the inhibition time follows the sequence
of 3,4-DHS>4,4V-DHS>resveratrol>4-HSf 3,5-DHS, same
to the sequence of the decrease of the oxygen uptake rate
mentioned above.
3.2. Inhibition of AAPH-induced microsomal peroxidation
by ROHs as studied by TBARS formation
Fig. 2 shows the TBARS formation during the AAPH-
induced peroxidation of rat liver microsomes. Similar to the
oxygen uptake experiments mentioned in the previous
section, the formation of TBARS was inhibited for a short
period of time upon AAPH initiation due to the endogenous
antioxidants in the microsomes. It is seen that the rate of
TBARS formation increased with the concentration of
AAPH used and the inhibition period correlated approxi-
mately inversely to the concentration of AAPH as expected.
Fig. 3 shows the inhibition of TBARS formation by resver-
atrol. It is clearly seen that resveratrol significantly sup-
pressed rate of TBARS formation and increased the
inhibition period in a dose-dependent manner. Other ROHs
showed the same behavior and a set of representative results
is shown in Fig. 4. All of these ROHs diminished the rate of
TBARS formation and increased the inhibition period. The
activity sequence is 3,4-DHS>4,4V-DHS>resveratrol>4-
HS>3,5-DHS, similar to that observed in the oxygen uptake
assay mentioned above.
3.3. The antioxidant effect of resveratrol and its analogues
on Fe2+/ascorbate-induced rat liver microsomal
peroxidation
Iron (Fe2 + plus a reducing reagent) is an extensively used
system for generating hydroxyl radicals to induce lipid
peroxidation that can be measured by the TBARS assay
[24]. In the present study, we used Fe2 +/ascorbate to induce
peroxidation of rat liver microsomes to investigate the
antioxidant effect of resveratrol and its analogues (ROHs).
It was found that ROHs preincubated with rat liver micro-
somes inhibited TBARS production in a dose-dependent
and time-dependent manner (Figs. 5 and 6). The antioxidant
activity also follows the sequence of 3,4-DHS>4,4V-
DHS>resveratrol>4-HS>3,5-DHS.
4. Discussion
The first event of lipid peroxidation is oxygen absorption
and a final product of the peroxidation is TBARS [20]. In the
present work, both the indexes were used to evaluate the
antioxidative activity of resveratrol and its analogue (ROHs)
to find the structural determinant responsible for the antiox-
idant activity in vitro. In addition, two different initiating
assays, that is, AAPHwhich produces alkyl radicals followed
by fast reaction with oxygen to give initiating alkyl peroxyl
radicals (Eqs. (1) and (2)) [14,25] and Fe2 +/ascorbate which
produces hydrogen peroxide and the latter generates
hydroxyl radicals by Fenton reaction (Eq. (3)) [26], were
used to initiate the microsomal peroxidation (Eqs. (4)–(7)).
AAPH ! 2RS þ N2 ð1Þ
RS þ O2 ! ROOS ð2Þ
Fe2þ þ H2O2 ! Fe3þ þ OH þ OHS ð3Þ
ROOS þ LH ! ROOHþ LS ð4Þ
OHS þ LH ! H2Oþ LS ð5Þ
LS þ O2 ! LOOS ð6Þ
LOOS þ LH ! LOOHþ LS ð7Þ
where RS is the alkyl radical generated from the thermal
decomposition of AAPH and LH represents a lipid molecule
with an abstractable hydrogen, that is, polyunsaturated fatty
acids in microsomes. In the presence of an antioxidant
molecule, AH, either the initiating peroxyl radical, hydroxyl
radical and/or the propagating lipid peroxyl radical can be
trapped and a new antioxidant radical, A., produced (Eqs.
(8)–(10)). If the A is a stabilized radical (e.g., a-tocopher-
oxyl radical or ascorbate radical) which can promote the rate-
limiting hydrogen abstraction reactions (Eqs. (8)–(10)) and
Fig. 6. Inhibition of TBARS formation during the Fe2 +/ascorbate-induced
peroxidation of rat liver microsomes by ROHs at 37 jC. The rat liver
microsomes were suspended in 0.1 M potassium phosphate buffer (pH 7.5)
at a protein concentration of 0.3 mg/ml. [FeSO4] = 10 AM; [ascorbate] = 100
AM; [ROHs]0 = 0.5 AM. (a) Native microsomes; (b) 3,5-DHS; (c) 4-HS; (d)
resveratrol; (e) 4,4V-DHS; (f) 3,4-DHS. Values represent meanF S.E. of
three experiments.
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undergo fast termination reactions (e.g., Eqs. (11) and (12)),
the peroxidation would be inhibited.
ROOS þ AH ! ROOHþ AS ð8Þ
OHS þ AH ! H2Oþ AS ð9Þ
LOOS þ AH ! LOOHþ AS ð10Þ
AS þ LOOS ! LOOA ð11Þ
2AS ! A Aþ others ð12Þ
The rate of the chain propagation, Rp for Eq. (7), the
inhibited rate of propagation by antioxidants, Rinh for Eq.
(10), and the inhibition period, tinh, can be easily obtained
from the oxygen uptake experiment (Fig. 1) and are listed in
Table 1. The fact that no new inhibition period could be
observed when ROHs were added after the intrinsic inhibi-
tion period (Fig. 1A) suggests that the ROHs react with the
initiating radicals in the bulk water phase (Eq. (8)), hence
diminish the effective rate of initiation, which in turn,
decreases the rate of propagation [14]. In this case, the
antioxidant activity of ROHs can be expressed by (Rinh/
Rp)100, designating the percentage inhibition of the peroxi-
dation which is independent on the reaction time.
On the other hand, if the ROHs were added before the
AAPH initiation, the inhibition period of the native micro-
somes was markedly prolonged (Fig. 1B). The synergistic
antioxidant efficiency, SE %, is generally expressed by Eq.
(13) [14] where AH is the endogenous antioxidant in the
microsomes. The results are listed in Table 1. In this case,
the antioxidant activity of ROHs can be evaluated by
comparing their tinh and/or SE %.




The antioxidant synergism of TOH with co-antioxidants
such as L-ascorbic acid (vitamin C) [27], h-carotene
[14d,21,28] and green tea polyphenols [14] has been exten-
sively studied and rationalized to be due to the regeneration
of TOH by these co-antioxidants. We have also proved
recently by using stopped-flow electron paramagnetic reso-
nance (EPR) spectroscopy that resveratrol and 3,4-DHS
could reduce a-tocopheroxyl radical (TO) to regenerate
TOH (Eq. (14)) with bimolecular rate constants of 0.23
102 and 3.0 102 M 1 s 1, respectively, in cetyl trimethy-
lammonium bromide (CTAB) micelles [15]. Therefore, it is
reasonable to suggest that the same mechanism might be
involved in the synergistic antioxidation reaction of ROHs
with the endogenous TOH in rat liver microsomes. The
concentration of TOH in the microsomes was determined to
be 0.3 nmol/mg protein.
TOS þ ROH ! TOHþ ROS ð14Þ
On the other hand, the prolonged inhibition period in the
presence of ROHs might also be caused by the reduced
initiation rate due to the ROHs. Since the inhibition period
is inversely proportional to the initial concentration of
AAPH [14], that is, the rate of initiation, reduced initiation
rate as shown in Fig. 1A should prolong the inhibition
period. It can be seen from Table 1 that the ratio of tinh(AH)/
tinh(ROH+AH) follows the same sequence of Rinh/Rp, sug-
gesting a correlation between the antioxidant synergism and
the rate of effective initiation. However, the appreciable
smaller value of tinh(AH)/tinh(ROH+AH) than Rinh/Rp in
case of 3,4-DHS, 4,4V-DHS and resveratrol implies that
the reduced rate of initiation is not the only reason for the
antioxidant synergism and the TOH regeneration reaction
(Eq. (14)) might also contribute to the antioxidant synergism
of these compounds.
It is clearly seen by comparison of Fig. 1 with Figs. 4–6
that the antioxidant activity of ROHs follows the same
sequence in spite of the activity being monitored by oxygen
uptake or by TBARS formation, and in spite of the perox-
idation being initiated by peroxyl radicals (generated by
AAPH) or by hydroxyl radicals (generated by Fe2 +/ascor-
bate). 3,4-DHS, which bears an ortho-diphenoxyl function-
ality, is remarkably active than resveratrol and other ROHs.
This is understood in view of the antioxidation mechanism
of phenolic antioxidants as exemplified in Scheme 1 [15].Scheme 1. Mechanism of 3,4-DHS inhibited peroxidation.
Scheme 2. Mechanism of 4,4V-DHS inhibited peroxidation.
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The ortho-hydroxyl would make the oxidation intermediate,
ortho-hydroxyl phenoxyl radical, more stable due to the
intramolecular hydrogen bonding interaction as evidenced
recently from both experiments [29] and theoretical calcu-
lations [30]. The theoretical calculation showed that the
hydrogen bond in ortho-OH phenoxyl radical is ca. 4 kcal/
mol stronger than that in the parent molecule catechol and
the bond dissociation energy (BDE) of catechol is 9.1 kcal/
mol lower than that of phenol and 8.8 kcal/mol lower than
that of resorcinol [30]. In addition, ortho-OH phenoxyl
radical shall be easier further oxidized to form the final
product ortho-quinone [29] (Scheme 1). The 4V-OH group
also enhanced the activity since the 4V-OH group can
stabilize the phenoxyl radical intermediate by resonance
through the trans-double bond and be further oxidized to the
para-quinone (Scheme 2). It has recently been proved that
the 4V-OH is more active than the meta-dihydroxyl groups in
resveratrol [4a,30,31].
5. Conclusions
Resveratrol and its analogues, that is, 3,4-DHS, 4,4V-
DHS, 4-HS and 3,5-DHS, are effective antioxidants against
both AAPH- and iron-induced peroxidation of rat liver
microsomes. The antioxidant mechanism may involve trap-
ping the initiating peroxyl radicals and/or hydroxyl radicals
and reducing a-tocopheroxyl radical (TO.) to regenerate the
endogenous TOH. The observation that trans-stilbene com-
pounds bearing ortho-diphenoxyl or para-diphenoxyl func-
tionalities possess remarkably higher antioxidant activity
than resveratrol gives us useful information for antioxidant
drug design.
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